This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Food insecurity could soon worsen for millions of families and result in devastating health outcomes.…
Originally broadcast June 5, 2024. A recent report from the Centers for Disease Control and…
Veterans Day, which is less than a month away, is a time to honor and…
Originally broadcast October 9, 2025 $44 billion in drugs that help Americans are purchased through…
Originally broadcast October 2, 2025 The federal government is shut down and the ripple effects…
Originally broadcast Tuesday, September 23, 2025 Happy anniversary to “Conversations on Health Care”! We posted…